Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of melatonin (Circadin) on glucose tolerance in MTNR1B rs10830963 variant carriers
2011-005360-22Phase 4Completed
- Sponsor
- Vasa Therapeutics
- Start
- Feb 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of melatonin in prediabetes, sponsored by Vasa Therapeutics. Primary endpoint: Glucose tolerance at 120 minutes during OGTT. Started Feb 2012; status: completed.
02
Drugs
melatonin
03
Conditions
prediabetes
Beyond the preview
Go deeper on 2011-005360-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005360-22.